These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27087162)

  • 1. Editorial.
    Brain Res; 2016 May; 1638(Pt A):1. PubMed ID: 27087162
    [No Abstract]   [Full Text] [Related]  

  • 2. [The stem cells and a problem of regeneration of peripheral nerves].
    Diel'tsova OI; Herashchenko SB; Chaĭkovskyĭ IuB
    Klin Khir; 2013 Jul; (7):65-8. PubMed ID: 24283050
    [No Abstract]   [Full Text] [Related]  

  • 3. Modelling multiple sclerosis using induced pluripotent stem cells.
    Martínez-Larrosa J; Matute-Blanch C; Montalban X; Comabella M
    J Neuroimmunol; 2020 Dec; 349():577425. PubMed ID: 33130461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cells: now open to discovery.
    Durak O; Tsai LH
    Cell Stem Cell; 2014 Jul; 15(1):4-6. PubMed ID: 24996162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of surface-immobilized extracellular matrices for the proliferation of neural progenitor cells derived from induced pluripotent stem cells.
    Komura T; Kato K; Konagaya S; Nakaji-Hirabayashi T; Iwata H
    Biotechnol Bioeng; 2015 Nov; 112(11):2388-96. PubMed ID: 25943789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent tumor tropism of induced pluripotent stem cells and induced pluripotent stem cell-derived neural stem cells in the mouse intracerebral glioma model.
    Yamazoe T; Koizumi S; Yamasaki T; Amano S; Tokuyama T; Namba H
    Int J Oncol; 2015 Jan; 46(1):147-52. PubMed ID: 25310640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells.
    Ogura A; Morizane A; Nakajima Y; Miyamoto S; Takahashi J
    Stem Cells Dev; 2013 Feb; 22(3):374-82. PubMed ID: 23020188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuronal cells derived from induced pluripotent stem cells to model motoneuron diseases].
    Bohl D
    Biol Aujourdhui; 2016; 210(1):27-36. PubMed ID: 27286578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine structure of neurally differentiated iPS cells generated from a multiple sclerosis (MS) patient: a case study.
    Herszfeld D; Payne NL; Sylvain A; Sun G; Bernard CC; Clark J; Sathananthan H
    Microsc Microanal; 2014 Dec; 20(6):1869-75. PubMed ID: 25335881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation, polarization, and migration of human induced pluripotent stem cell-derived neural progenitor cells co-cultured with a human glial cell line with radial glial-like characteristics.
    Bamba Y; Shofuda T; Kanematsu D; Nonaka M; Yamasaki M; Okano H; Kanemura Y
    Biochem Biophys Res Commun; 2014 May; 447(4):683-8. PubMed ID: 24755070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging neuronal precursors from amniotic fluid-derived down syndrome induced pluripotent stem cells.
    Mukherjee S; Pipino C; David AL; DeCoppi P; Thrasher AJ
    Hum Gene Ther; 2014 Aug; 25(8):682-3. PubMed ID: 25136915
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotrophic activity of jiadifenolide on neuronal precursor cells derived from human induced pluripotent stem cells.
    Shoji M; Nishioka M; Minato H; Harada K; Kubo M; Fukuyama Y; Kuzuhara T
    Biochem Biophys Res Commun; 2016 Feb; 470(4):798-803. PubMed ID: 26809091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse-induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy.
    Liu SP; Fu RH; Wu DC; Hsu CY; Chang CH; Lee W; Lee YD; Liu CH; Chien YJ; Lin SZ; Shyu WC
    Stem Cells Dev; 2014 Feb; 23(4):421-33. PubMed ID: 24266622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.
    Qiang L; Fujita R; Abeliovich A
    Neuron; 2013 Jun; 78(6):957-69. PubMed ID: 23791192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anisotropic effects of mechanical strain on neural crest stem cells.
    Li X; Chu JS; Yang L; Li S
    Ann Biomed Eng; 2012 Mar; 40(3):598-605. PubMed ID: 22109803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Protocol to Differentiate Induced Pluripotent Stem Cells by Neuronal microRNAs to Provide a Suitable Cellular Model.
    Zare M; Soleimani M; Akbarzadeh A; Bakhshandeh B; Aghaee-Bakhtiari SH; Zarghami N
    Chem Biol Drug Des; 2015 Aug; 86(2):232-8. PubMed ID: 25430972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and applications of induced pluripotent stem cells.
    Pietronave S; Prat M
    Can J Physiol Pharmacol; 2012 Mar; 90(3):317-25. PubMed ID: 22364544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.